These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 16735435)
1. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components. Papadopoulos CJ; Carson CF; Hammer KA; Riley TV J Antimicrob Chemother; 2006 Aug; 58(2):449-51. PubMed ID: 16735435 [TBL] [Abstract][Full Text] [Related]
2. Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1,8-cineole, and alpha-terpineol. Papadopoulos CJ; Carson CF; Chang BJ; Riley TV Appl Environ Microbiol; 2008 Mar; 74(6):1932-5. PubMed ID: 18192403 [TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal activity of the tea tree (Melaleuca alternifolia) essential oil and its major components against plant pathogens. Terzi V; Morcia C; Faccioli P; Valè G; Tacconi G; Malnati M Lett Appl Microbiol; 2007 Jun; 44(6):613-8. PubMed ID: 17576222 [TBL] [Abstract][Full Text] [Related]
4. Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol. Thomsen NA; Hammer KA; Riley TV; Van Belkum A; Carson CF Int J Antimicrob Agents; 2013 Apr; 41(4):343-51. PubMed ID: 23481659 [TBL] [Abstract][Full Text] [Related]
5. Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes. Longbottom CJ; Carson CF; Hammer KA; Mee BJ; Riley TV J Antimicrob Chemother; 2004 Aug; 54(2):386-92. PubMed ID: 15254026 [TBL] [Abstract][Full Text] [Related]
6. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. Mondello F; De Bernardis F; Girolamo A; Cassone A; Salvatore G BMC Infect Dis; 2006 Nov; 6():158. PubMed ID: 17083732 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Banes-Marshall L; Cawley P; Phillips CA Br J Biomed Sci; 2001; 58(3):139-45. PubMed ID: 11575735 [TBL] [Abstract][Full Text] [Related]
8. In vitro antiviral activity of Melaleuca alternifolia essential oil. Garozzo A; Timpanaro R; Bisignano B; Furneri PM; Bisignano G; Castro A Lett Appl Microbiol; 2009 Dec; 49(6):806-8. PubMed ID: 19843207 [TBL] [Abstract][Full Text] [Related]
9. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Hart PH; Brand C; Carson CF; Riley TV; Prager RH; Finlay-Jones JJ Inflamm Res; 2000 Nov; 49(11):619-26. PubMed ID: 11131302 [TBL] [Abstract][Full Text] [Related]
10. Antifungal modes of action of tea tree oil and its two characteristic components against Botrytis cinerea. Yu D; Wang J; Shao X; Xu F; Wang H J Appl Microbiol; 2015 Nov; 119(5):1253-62. PubMed ID: 26294100 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells. Loughlin R; Gilmore BF; McCarron PA; Tunney MM Lett Appl Microbiol; 2008 Apr; 46(4):428-33. PubMed ID: 18298453 [TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. Hammer KA; Carson CF; Riley TV J Appl Microbiol; 2003; 95(4):853-60. PubMed ID: 12969301 [TBL] [Abstract][Full Text] [Related]
13. The outer membrane of Pseudomonas aeruginosa NCTC 6749 contributes to its tolerance to the essential oil of Melaleuca alternifolia (tea tree oil). Mann CM; Cox SD; Markham JL Lett Appl Microbiol; 2000 Apr; 30(4):294-7. PubMed ID: 10792649 [TBL] [Abstract][Full Text] [Related]
14. The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Brand C; Ferrante A; Prager RH; Riley TV; Carson CF; Finlay-Jones JJ; Hart PH Inflamm Res; 2001 Apr; 50(4):213-9. PubMed ID: 11392609 [TBL] [Abstract][Full Text] [Related]
15. Effects of Melaleuca alternifolia (tea tree) essential oil and the major monoterpene component terpinen-4-ol on the development of single- and multistep antibiotic resistance and antimicrobial susceptibility. Hammer KA; Carson CF; Riley TV Antimicrob Agents Chemother; 2012 Feb; 56(2):909-15. PubMed ID: 22083482 [TBL] [Abstract][Full Text] [Related]
16. Plants of the Melaleuca Genus as Antimicrobial Agents: From Farm to Pharmacy. Sharifi-Rad J; Salehi B; Varoni EM; Sharopov F; Yousaf Z; Ayatollahi SA; Kobarfard F; Sharifi-Rad M; Afdjei MH; Sharifi-Rad M; Iriti M Phytother Res; 2017 Oct; 31(10):1475-1494. PubMed ID: 28782167 [TBL] [Abstract][Full Text] [Related]
17. Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections. Lam NS; Long X; Su XZ; Lu F Biomed Pharmacother; 2020 Oct; 130():110624. PubMed ID: 33503761 [TBL] [Abstract][Full Text] [Related]
18. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Kwieciński J; Eick S; Wójcik K Int J Antimicrob Agents; 2009 Apr; 33(4):343-7. PubMed ID: 19095413 [TBL] [Abstract][Full Text] [Related]
19. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Walton SF; McKinnon M; Pizzutto S; Dougall A; Williams E; Currie BJ Arch Dermatol; 2004 May; 140(5):563-6. PubMed ID: 15148100 [TBL] [Abstract][Full Text] [Related]
20. Determination of Legionella pneumophila susceptibility to Melaleuca alternifolia Cheel (tea tree) oil by an improved broth micro-dilution method under vapour controlled conditions. Mondello F; Girolamo A; Scaturro M; Ricci ML J Microbiol Methods; 2009 May; 77(2):243-8. PubMed ID: 19264101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]